Related Experiment Video
Updated: Nov 1, 2025

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Growth in children on kidney replacement therapy: a review of data from patient registries
Marjolein Bonthuis1, Jérôme Harambat2, Kitty J Jager3
1ESPN/ERA-EDTA Registry, Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, J1B-108.1, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands. m.bonthuis@amsterdamumc.nl.
Insights
Children with chronic kidney disease (CKD) on kidney replacement therapy (KRT) show improved final height due to better management. Early growth, especially by age two, is crucial for predicting final height in these children.
Area of Science:
- Pediatric Nephrology
- Growth and Development
- Chronic Kidney Disease Management
Background:
- Growth retardation is a significant complication for children with chronic kidney disease (CKD) requiring kidney replacement therapy (KRT).
- Improved growth in childhood CKD correlates with better outcomes in morbidity and mortality.
- Advances in conservative management, dialysis, immunosuppression, and transplantation have improved final height over time.
Purpose of the Study:
- To analyze the relationship between early growth and final height in pediatric patients undergoing KRT.
- To highlight the critical role of infancy and early childhood in determining final stature for children with CKD.
Main Methods:
- Analysis of data from pediatric international registries, including the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry.
- Examination of growth patterns and final height outcomes in children on KRT.
Main Results:
- Preliminary data confirms a significant association between final height and height attained at 2 years of age in children on KRT.
- Infancy represents a critical period for linear growth, impacting final adult height.
Conclusions:
- Early growth assessment, particularly by age two, is vital for predicting final height in children with CKD on KRT.
- Continued improvements in CKD management contribute to better growth outcomes and final height in pediatric patients.
Abstract:
Growth retardation is a major complication in children with chronic kidney disease (CKD) and on kidney replacement therapy (KRT). Conversely, better growth in childhood CKD is associated with an improvement in several hard morbidity-mortality endpoints. Data from pediatric international registries has demonstrated that improvements in the overall conservative management of CKD, the search for optimal dialysis, and advances in immunosuppression and kidney transplant techniques have led to a significant improvement of final height over time. Infancy still remains a critical period for adequate linear growth, and the loss of stature during the first years of life influences final height. Preliminary new original data from the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry confirm an association between the final height and the height attained at 2 years in children on KRT.
Related Concept Videos
Kidney Transplant I: Introduction
Continuous Renal Replacement Therapy
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care

